Cadonilimab with radiation for recurrent endometrial cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a combined treatment of the immunotherapy drug cadonilimab plus radiation and chemotherapy for endometrial cancer that has come back or spread to only a few places. The goal is to see if this combination can help control the cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your cancer has come back (recurred) or spread to a limited number of spots (up to 5) after initial treatment.
- You are able to do most daily activities without help (ECOG 0 or 1).
- You have not had a severe immune reaction to a previous immunotherapy.
- You do not have an active autoimmune disease that requires treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new drug called cadonilimab combined with chemotherapy for women with endometrial cancer that has come back or spread. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial studies whether adding cadonilimab (an immune therapy) to standard radiation can improve treatment for locally advanced cervical cancer. It may help your immune system work better against the cancer while radiation shrinks it.
This trial tests a drug called cadonilimab in women with cervical cancer that has returned or spread. The goal is to see how well it works in real life and to help manage the cancer.
This study tests a combination of two treatments: a drug called cadonilimab (a type of immunotherapy that helps your immune system fight cancer) and radiation therapy. It is for people with advanced cervical cancer who cannot receive the usual chemotherapy drug cisplatin, and aims to see if this combination is safe and effective.
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
This trial tests a new immunotherapy drug (cadonilimab) combined with standard chemoradiation for cervical cancer that has spread to a few other places in the body. It aims to see if this combination can help control the cancer better.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.